Companies / Clarus Therapeutics Inc
Clarus Therapeutics Inc
CRXTCIK 1286162
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $5.22M | -2.1M -68.25% | 958,989 | medium |
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $4.21M | -1.7M -68.25% | 773,599 | medium |
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $34.5K | -14K -68.25% | 6,340 | low |
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $19.2K | -8K -68.25% | 3,528 | low |
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $14.5K | -6K -68.26% | 2,661 | low |
| Apr 20, 2022 | Thomas McNerney & Partners LP 10% owner | Sell Open-market sale | Common Stock | $2.9K | -1K -68.23% | 542 | low |
| Sep 9, 2021 | Hernandez Joseph Director | Other Other (per filing) | Common Stock | $0 | -135K -9.39% | 1,302,500 | low |
| Sep 9, 2021 | Hernandez Joseph Director | Exercise Option exercise | Common Stock | $0 | +1.4M | 1,437,500 | low |